5 Breast Cancer Clinical Trials in Berkeley, CA (2026)

Q: How do I join a clinical trial in Berkeley?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Berkeley research site will contact you.

Recruiting Breast Cancer Studies in Berkeley

NCT06492616Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal G...

Berkeley, CAPHASE34,220 participantsStemline Therapeutics, Inc.

View Study Details

NCT06058377Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-I...

Berkeley, CAPHASE33,680 participantsNational Cancer Institute (NCI)

View Study Details

NCT07391774Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high anatomic stage breast...

Berkeley, CAPHASE31,978 participantsNational Cancer Institute (NCI)

View Study Details

NCT05633654Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatmen...

Berkeley, CAPHASE31,514 participantsGilead Sciences

View Study Details

NCT06075953Recruiting

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

The goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an early stage of breast cancer, can be an effe...

Berkeley, CAPHASE2400 participantsQuantumLeap Healthcare Collaborative

View Study Details

About Breast Cancer Clinical Trials in Berkeley

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 5 breast cancer clinical trials recruiting participants in Berkeley, CA. These studies are seeking a combined 11,792 participants. Research is being sponsored by Stemline Therapeutics, Inc., National Cancer Institute (NCI), Gilead Sciences and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Berkeley — FAQ

Are there breast cancer clinical trials in Berkeley?

Yes, there are 5 breast cancer clinical trials currently recruiting in Berkeley, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Berkeley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Berkeley research site will contact you about next steps.

Are clinical trials in Berkeley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Berkeley studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 5 active trials in Berkeley are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 22, 2026 from ClinicalTrials.gov